Bortezomib-Based Versus Nonbortezomib-Based Post-Transplantation Treatment in Multiple Myeloma Patie

来源 :中华医学生物免疫学会第二届学术年会 | 被引量 : 0次 | 上传用户:suanjava
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective:The aim of this meta-analysis of data from phase Ⅲ studies is to characterize efficacy and safety of bortezomib-based versus nonbortezomib-based post-transplantation therapy in patients with multiple myeloma (MM).
其他文献
Diabetes and cardiovascular diseases(CVDs),including coronary heart disease,stroke and other circulatory diseases,are the number one cause of death and disability globally.The increasing incidence of
会议
In order to assure the safety and efficiency of biopharmacueticals,the CFDA has issued a series of regulations related to biopharmacueticals in China.NIFDC has established a strong platform to perform
Upon the outbreak of human cases of avian influenza virus(H7N9)infection in China since April 2013,the vaccine development was started soon after manufacturers received the vaccine strains.However,the
Diabetes is a complex disease with heterogeneity in disease phenotype,variable patient response to treatment and possible risk associated with particular therapeutic strategies.The latest guidelines f
会议
It has been challenging to develop an effective HIV vaccine but the lessons learned from HIV vaccine development will have broad impact to the future of translational medicine.The most important lesso
会议
Chemogenomics is an interdisciplinary research that utilizes chemicals/drugs and associated genomics data to systematically identify and analyze chemicals-protein/protein interactions for the purpose
Increasing evidence suggests that aberrant activation of the androgen receptor(AR)plays a pivotal role in prostate cancer development and castration-resistant progression after androgen deprivation th
We report the identification and characterization of a five-carbon protein posttranslationai modification(PTM)called lysine glntarylation(Kglu).This protein modification was detected by immunoblot and
会议
Firstly,he analyzes situations regarding development of regional medical information platforms at home and abroad,which lays a foundation for the research of big data; secondly,he analyzes challenges
会议
目的:食管癌是最常见的消化道恶性肿瘤之一.近年来,过继性免疫细胞治疗在抑制食管癌复发转移中取得了良好的临床疗效.但也有文献报道部分患者对该治疗无应答.动物实验结果显示,效应性T淋巴细胞向肿瘤组织的归巢能力是过继免疫治疗发挥疗效的决定因素之一.趋化因子在淋巴细胞的体内迁移运动中起重要作用,因此研究鉴定T淋巴细胞向食管癌组织归巢中的关键趋化因子对于改进过继性细胞免疫治疗有着重要意义.本研究筛选食管癌患